Paying the price for eating ice cream: is excessive GLP-1 signaling in the brain the culprit?
- PMID: 18809947
- PMCID: PMC2582920
- DOI: 10.1210/en.2008-0932
Paying the price for eating ice cream: is excessive GLP-1 signaling in the brain the culprit?
Figures

Comment on
-
Brain glucagon-like peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance and reduces energy expenditure.Endocrinology. 2008 Oct;149(10):4768-77. doi: 10.1210/en.2008-0180. Epub 2008 Jun 12. Endocrinology. 2008. PMID: 18556349
Similar articles
-
Glucagon-like peptide 1 and the brain: central actions-central sources?Auton Neurosci. 2011 Apr 26;161(1-2):14-9. doi: 10.1016/j.autneu.2010.09.008. Epub 2010 Oct 14. Auton Neurosci. 2011. PMID: 20951098 Review.
-
Unexpectedly increased anorexigenic postprandial responses of PYY and GLP-1 to fast ice cream consumption in adult patients with Prader-Willi syndrome.Clin Endocrinol (Oxf). 2014 Oct;81(4):542-50. doi: 10.1111/cen.12395. Epub 2014 Jan 20. Clin Endocrinol (Oxf). 2014. PMID: 24372155 Clinical Trial.
-
Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1.Endocrinology. 2001 Mar;142(3):1148-55. doi: 10.1210/endo.142.3.8034. Endocrinology. 2001. PMID: 11181530
-
Dopamine signaling in the amygdala, increased by food ingestion and GLP-1, regulates feeding behavior.Physiol Behav. 2014 Sep;136:135-44. doi: 10.1016/j.physbeh.2014.02.026. Epub 2014 Feb 21. Physiol Behav. 2014. PMID: 24560840
-
Anorexigenic effects of GLP-1 and its analogues.Handb Exp Pharmacol. 2012;(209):185-207. doi: 10.1007/978-3-642-24716-3_8. Handb Exp Pharmacol. 2012. PMID: 22249815 Review.
Cited by
-
Glucagon-like peptide 1 receptor induced suppression of food intake, and body weight is mediated by central IL-1 and IL-6.Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):16199-204. doi: 10.1073/pnas.1306799110. Epub 2013 Sep 18. Proc Natl Acad Sci U S A. 2013. PMID: 24048027 Free PMC article.
-
Interleukin-6 in the central amygdala is bioactive and co-localised with glucagon-like peptide-1 receptor.J Neuroendocrinol. 2019 Jun;31(6):e12722. doi: 10.1111/jne.12722. Epub 2019 May 23. J Neuroendocrinol. 2019. PMID: 31033078 Free PMC article.
-
World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease: part 4.Diabetes Care. 2011 Oct;34(10):e152-7. doi: 10.2337/dc11-1306. Diabetes Care. 2011. PMID: 21949229 Free PMC article. No abstract available.
References
-
- Sinclair EM, Drucker DJ 2005 Proglucagon-derived peptides: mechanisms of action and therapeutic potential. Physiology (Bethesda) 20:357–365 - PubMed
-
- Dumoulin V, Moro F, Barcelo A, Dakka T, Cuber JC 1998 Peptide YY, glucagon-like peptide-1, and neurotensin responses to luminal factors in the isolated vascularly perfused rat ileum. Endocrinology 139:3780–3786 - PubMed
-
- Dube PE, Brubaker PL 2004 Nutrient, neural and endocrine control of glucagon-like peptide secretion. Horm Metab Res 36:755–760 - PubMed
-
- Chu ZL, Carroll C, Alfonso J, Gutierrez V, He H, Lucman A, Pedraza M, Mondala H, Gao H, Bagnol D, Chen R, Jones RM, Behan DP, Leonard J 2008 A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release. Endocrinology 149:2038–2047 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical